COMMUNIQUÉS West-GlobeNewswire

MedSpa Board and QUAD A Provide Joint Guidance on IV Infusion Safety Following Recent Safety Concerns
06/10/2026
HIGHLAND PARK, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Following recent FDA and CDC safety communications involving compounded injectable glutathione and related adverse events, QUAD A and MedSpa Board are providing [...]
Fast Company Names Veyond Metaverse a 2026 Next Big Things in Tech Winner for OceanMD, XR Telemedicine for Ships and Remote Sites
06/10/2026
OceanMD brings a remote physician virtually beside the medic on ships and offshore sites where specialist help can be days away SAN FRANCISCO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Veyond Metaverse , a developer of [...]
Going Beyond Addiction
06/10/2026
San Diego-based Shoreline Recovery Center highlights the importance of long-term support for individuals following addiction treatment San Diego, CA., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Achieving sobriety after addiction [...]
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
06/10/2026
After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recommended completing the study with the originally planned number of patients (N=33); the study remains blinded As of the [...]
API Innovation Center Launches the U.S.’ First Benchmark for Pharmaceutical Supply Chain Fragility
06/10/2026
More than 550 million prescriptions were filled for medicines with High or Severe supply-chain fragility, according to APIIC’s new national benchmark ST. LOUIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- More than 550 million [...]
Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin
06/10/2026
New triple-acid treatment booster is designed to help clarify, balance, and fade visible signs of blemish-prone skin while helping maintain hydration LONG BEACH, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth [...]
Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
06/10/2026
NORCROSS, Ga., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced participation in the upcoming AASLD Liver [...]
Stryker announces leadership succession
06/10/2026
Portage, Michigan, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kevin Lobo to transition to Executive Chair of the Board of Directors Current President and COO Spencer Stiles appointed Chief Executive Officer Leadership transition [...]
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
06/10/2026
Virtual Event Featuring Jonathan M. Hernandez, M.D, Investigator, Surgical Oncology Program, NCI/CCR, to Be Held October 15, 2026, at 8am ET PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology [...]
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
06/10/2026
Common Stock PIPE Strengthens Telomir’s Capital Position as Company Advances Telomir-Zn into Clinical Development Under FDA-Cleared IND in Triple-Negative Breast Cancer (TNBC) MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- [...]
Oak Hill Bio Appoints Joerg Hipp, PhD as Chief Translational Science Officer
06/10/2026
CAMBRIDGE, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- OHB Pediatrics Ltd d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, today announced the appointment of Joerg Hipp, PhD as Chief Translational [...]
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
06/10/2026
Company to host conference call and webcast following the presentation on Tuesday, October 20, at 8:00 a.m. EDT BOSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “ [...]
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
06/10/2026
HIGH POINT, N.C., Oct. 06, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), [...]
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
06/10/2026
TAIPEI, Taiwan, and BOTHELL, Wash., Oct. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and [...]
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
06/10/2026
Former Gilead and Amgen executive joins Entera with over 35 years of experience advancing and commercializing impactful and blockbuster therapies TEL AVIV, Israel, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. ( [...]
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
06/10/2026
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
06/10/2026
Segment features Kevin Lundquist discussing his decision to join Outlook Therapeutics and the Company’s path forward following the FDA approval of LYTENAVA™ Access the segment here ISELIN, N.J., Oct. 06, 2026 (GLOBE [...]
Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026
06/10/2026
COPENHAGEN, Denmark, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest advances in its hypoparathyroidism and achondroplasia programs will be showcased during ASBMR [...]
Applied Biologics Announces Manufacturing Milestone in APPB-515 Osteoarthritis Gene Therapy Program
06/10/2026
Successful production of reference protein advances proprietary protein engineering and gene therapy development program SCOTTSDALE, Ariz., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, LLC today announced the [...]

Pages